Profiel
Masayuki Kobayashi is Chairman at Taiho Oncology, Inc. since 2014, President & Representative Director at Taiho Pharmaceutical Co., Ltd. since 2012, and Director at Otsuka Holdings Co., Ltd. since 2017.
Formerly, Mr. Kobayashi was Chief Executive Officer at Otsuka America, Inc.
Actieve functies van Masayuki Kobayashi
| Bedrijven | Functie | Begin |
|---|---|---|
| OTSUKA HOLDINGS CO., LTD. | Directeur/Bestuurslid | 30-03-2017 |
Taiho Pharmaceutical Co., Ltd.
Taiho Pharmaceutical Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Develops oncology drugs | President | 03-04-2012 |
Taiho Oncology, Inc.
Taiho Oncology, Inc. Pharmaceuticals: MajorHealth Technology Engages in development and commercialization of orally administered anti-cancer agents for tumor types | Voorzitter | 01-04-2014 |
Eerdere bekende functies van Masayuki Kobayashi
| Bedrijven | Functie | Einde |
|---|---|---|
Otsuka America, Inc.
Otsuka America, Inc. Pharmaceuticals: MajorHealth Technology Operates as a holding company whose subsidiaries manufactures and sells pharmaceutical, nutraceutical products & consumer markets | President | 31-03-2012 |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 4 |
|---|---|
Taiho Pharmaceutical Co., Ltd.
Taiho Pharmaceutical Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Develops oncology drugs | Commercial Services |
Otsuka America, Inc.
Otsuka America, Inc. Pharmaceuticals: MajorHealth Technology Operates as a holding company whose subsidiaries manufactures and sells pharmaceutical, nutraceutical products & consumer markets | Health Technology |
Otsuka Holdings Co., Ltd.
Otsuka Holdings Co., Ltd. Pharmaceuticals: MajorHealth Technology Operates as an investment holding company with interests in pharmaceutical preparations | Health Technology |
Taiho Oncology, Inc.
Taiho Oncology, Inc. Pharmaceuticals: MajorHealth Technology Engages in development and commercialization of orally administered anti-cancer agents for tumor types | Health Technology |
















